Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase III milestone reached for Ethyol in new indication

Feb. 13, 1998

Antitumor arabinofuranosylcytosines from Yamasa

Feb. 13, 1998

Chiroscience and Bristol-Myers Squibb collaborate on MMP inhibitors for cancer

Feb. 12, 1998

Chinese investigators evaluate new MDR-reversing agent

Feb. 12, 1998

Celltech reports crosslinked antibodies for cancer indications

Feb. 12, 1998

Targeted Genetics to report tgDCC-E1A clinical data

Feb. 11, 1998

Topoisomerase I inhibitor tested in phase I trial

Feb. 11, 1998

Vorozole safe and effective in phase II EORTC study

Feb. 11, 1998

GeneMedicine and Corange progress in cancer alliance

Feb. 11, 1998

Novel mitomycin C derivative reported by Sagami

Feb. 11, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...